Virtual Medicinal Product (VMP)
-
Lamivudine 50mg/5ml oral solution
Name Details
Current Name
Lamivudine 50mg/5ml oral solution
|
Start Date
22-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral solution
- Ontology Form/Route
- solution.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AF05
BNF |
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05030100
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41790311000001101 |
12-05-2023 |
|
324825008 |
22-11-2002 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
Lamivudine |
Based on Ingredient Substance |
|
10 mg |
1 ml |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Lamivudine
-
VMP
(Current) Lamivudine 50mg/5ml oral solution
Virtual Medicinal Product Pack (VMPP) Information
240 ml |
3901 |
Part VIIIA Category C |